Showing 33–44 of 44 results
-
Sale!

₹191.00 Original price was: ₹191.00.₹153.00Current price is: ₹153.00.Sitadiet‑DM 10/500/500 Tablet is an oral antidiabetic combination medicine used for the treatment of Type 2 Diabetes Mellitus.
It contains three drugs:
Dapagliflozin 10 mg
Sitagliptin 100 mg
Metformin 500 mg (SR)
-
Sale!

₹230.00 Original price was: ₹230.00.₹184.00Current price is: ₹184.00.SITAGLYS D3 100/10/500 Tablet is an oral anti-diabetic combination medicine used for the treatment of Type 2 Diabetes Mellitus when blood sugar is not controlled with single or dual therapy.
It contains Sitagliptin (100 mg) + Dapagliflozin (10 mg) + Metformin (500 mg).
-
Sale!

₹212.00 Original price was: ₹212.00.₹170.00Current price is: ₹170.00.Sitapride-M 100/500 is an oral anti-diabetic medicine used for the treatment of Type-2 Diabetes Mellitus. It is a combination of Sitagliptin (100 mg) and Metformin (500 mg) which helps control high blood sugar levels.
-
Sale!

₹111.00 Original price was: ₹111.00.₹88.00Current price is: ₹88.00.Composition: Sitagliptin 50 mg + Metformin 500 mg
Drug Class: Antidiabetic medicine (DPP-4 inhibitor + Biguanide)
Uses:
- Used for the treatment of Type 2 Diabetes Mellitus.
- Helps control high blood sugar levels along with diet and exercise.
-
Sale!

₹320.00 Original price was: ₹320.00.₹256.00Current price is: ₹256.00.Sugar Free refers to products that contain little or no sucrose (table sugar) and are sweetened using artificial or natural low-calorie sweeteners. These are commonly used by people with Diabetes Mellitus or those who want to reduce calorie intake. Sugar-free products help control blood glucose levels and support weight management.
-
Sale!

₹373.00 Original price was: ₹373.00.₹298.00Current price is: ₹298.00.Tenepride 20 Tablet is an antidiabetic medicine used to control Type 2 Diabetes Mellitus. It contains Teneligliptin 20 mg, which belongs to the DPP-4 inhibitor class of drugs. It helps lower blood sugar by increasing insulin release and decreasing glucagon levels, especially after meals.
-
Sale!

₹145.00 Original price was: ₹145.00.₹116.00Current price is: ₹116.00.TRIGLIMIPR-2 is an oral antidiabetic combination tablet used to treat Type 2 Diabetes Mellitus when diet and exercise alone are not enough to control blood sugar levels.
-
Sale!

₹132.00 Original price was: ₹132.00.₹106.00Current price is: ₹106.00.Vildamac M 50/500 is an oral antidiabetic medicine used to treat Type 2 Diabetes Mellitus when diet and exercise alone are not sufficient to control blood sugar. It is a combination drug containing Vildagliptin (50 mg) and Metformin Hydrochloride (500 mg).
-
Sale!

₹182.00 Original price was: ₹182.00.₹146.00Current price is: ₹146.00.Voglimac-GM 1 Tablet is an anti-diabetic medicine used to control blood sugar levels in patients with Type 2 Diabetes Mellitus. It is a combination medicine that improves insulin secretion and reduces glucose absorption from food.
-
Sale!

₹209.00 Original price was: ₹209.00.₹167.00Current price is: ₹167.00.VYSOV-M 50/500 mg is an anti-diabetic medicine used for the treatment of Type-2 Diabetes Mellitus when diet and exercise alone are not sufficient to control blood sugar levels. It contains Vildagliptin (50 mg) and Metformin (500 mg). These medicines help increase insulin secretion, reduce glucose production in the liver, and improve the body’s response to insulin, thereby lowering blood glucose levels.
-
Sale!

₹246.00 Original price was: ₹246.00.₹197.00Current price is: ₹197.00.Zoryl-M 1 Tablet is an oral antidiabetic medicine used to treat Type-2 diabetes mellitus. It is a combination of Glimepiride (1 mg) and Metformin, which help control blood sugar levels in patients whose diabetes is not controlled by diet and exercise alone. It works by increasing insulin release from the pancreas and improving the body’s response to insulin.
-
Sale!

₹82.00 Original price was: ₹82.00.₹66.00Current price is: ₹66.00.Zukanorm 50 Tablet is an oral antidiabetic medicine used for the treatment of Type 2 Diabetes Mellitus.
It contains Vildagliptin 50 mg, which belongs to the DPP-4 inhibitor class of drugs.
End of content
End of content